Redirecting to https://www.merck.com/news/fda-approves-keytruda-pembrolizumab-as-adjuvant-treatment-following-surgical-resection-and-platinum-based-chemotherapy-for-patients-with-stage-ib-t2a-%e2%89%a54-centimeters-ii-or-iiia-non/...

Click here if your browser doesn't automatically take you to this page.